A novel asthma spacer device, the "Funhaler", incorporates incentive toys which are isolated from the main inspiratory circuit by a valve. Here we show that its use does not compromise drug delivery. Improved adherence combined with satisfactory delivery characteristics suggest that the Funhaler may be useful for management of young asthmatics.
No takes yet. Share an insight, caveat, or question.
Paul M. Watt (2003) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: